Jacqueline Zummo, MPH, MBA | Psychiatrist.com

Original Research

Metabolic Effects of Aripiprazole Lauroxil

November 23, 2016

Aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating schizophrenia symptoms in a recent RCT. But how does it stack up against other antipsychotics in terms...

Henry A. Nasrallah, John W. Newcomer, Robert Risinger, et al

Letter to the Editor

Oral and Long-Acting Injectable Naltrexone: Removal of Boxed Warning for Hepatotoxicity

December 23, 2015

Jeffrey Stoddard, Jacqueline Zummo

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

August 26, 2015

Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah, et al

Article

Eszopiclone Treatment for Insomnia: Effect Size Comparisons in Patients With Primary Insomnia and Insomnia With Medical and Psychiatric Comorbidity

July 5, 2012

Review results from a post hoc analysis that compared the treatment effect size of eszopiclone 3 mg for insomnia in patients with a diagnosis of primary insomnia and in...

Andrew D. Krystal, W. Vaughn McCall, Maurizio Fava, et al